Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial.

Phyo, Aung Pyae

Antimalarial activity of artefenomel (OZ439), a novel synthetic antimalarial endoperoxide, in patients with Plasmodium falciparum and Plasmodium vivax malaria: an open-label phase 2 trial. [electronic resource] - The Lancet. Infectious diseases Jan 2016 - 61-69 p. digital

Publication Type: Clinical Trial, Phase II; Controlled Clinical Trial; Journal Article; Multicenter Study; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1474-4457

10.1016/S1473-3099(15)00320-5 doi


Adamantane--administration & dosage
Adolescent
Adult
Antimalarials--administration & dosage
Cohort Studies
Dose-Response Relationship, Drug
Female
Half-Life
Humans
Malaria, Falciparum--drug therapy
Malaria, Vivax--drug therapy
Male
Middle Aged
Peroxides--administration & dosage
Thailand--epidemiology
Young Adult